Post on 20-Aug-2015
• Per capita healthcare expenditure is far below global average (lowest is Vietnam and Indonesia).
• Shortage of healthcare professionals. Health care workers in APAC is 6.8 per 1,000 population, compared to 18.9 in Europe and 24.8 in the Americas in 2010.
• Access to healthcare and distribution limited in emerging markets.
Market Restraints
• By 2020, Chronic disease deaths in APAC will grow at 20%.
• 15% of the 37 million deaths worldwide is related to Pandemic and epidemic diseases, 1/3 of such was from APAC.
• Private expenditures is increasing in China and India, private spending accounted for 49.9% and 67.2% respectively in 2009.
Market Drivers
APAC Share
Global vs. APAC: The New FrontierIn 2011, APAC is estimated to be 28.5% of global market
28.5 % 34.6%
Global & APAC Healthcare Revenues US$ Bn, 2011-2015
• By 2015, APAC could represent 34.6% of global market
2011 2012 2013 2014 20150.0
200.0
400.0
600.0
800.0
1000.0
1200.0
1400.0
1600.0
1800.0
356.5 396.4 440.1 491.7 562.1
895.6928.8
978.11017.5
1060.7
APAC($ Billion)
Rest of the World($ Billion)
CAGR12.1%CAGR12.1%
CAGR4.3%
CAGR4.3%
2011 2012 2013 2014 20150.0
200.0
400.0
600.0
800.0
1,000.0
1,200.0
252.1 278.4 309.4 346.1 389.4
636.0 649.0677.6
707.4738.5
APAC($ Billion)
Rest of the World($ Billion)
Pharmaceuticals & Biotechnology, US$ Bn, 2011-2015
Market Drivers
• Increased long term use of multiple and specialized drugs for the aging population.
• Enhanced health awareness and purchasing power boosting over-the-counter purchase.
• Government support for generics/bio-similars.
• Increased disease incidence boosted by availability and usage of new diagnostic tools.
Market Restraints
• Patent expiry of major pharmaceutical products.
• Cost control measures by various governments.
• In markets with strong local manufacturing, government tenders favor local manufacturers.
Pharma market will grow at almost triple the rate compared with the rest of the world, accounting for 1/3rd of total by 2015
CAGR11.5%CAGR11.5%
CAGR3.8%
CAGR3.8%
28.4% 34.5%APAC Market Share
• Technology based pricing approval remains a hurdle.
• Public hospitals practice- lowest price bidding, leads to price war.
• Inadequate training or certification for allied healthcare staff.
Market Restraints
• By 2015, Cardiology market is expected to reach $18 billion.
• Surgical procedures are growing at 12.0 %.• Japan and South Korea lead MIS in APAC,
demand for MIS increasing in Singapore, Malaysia, Australia and Thailand, driving devices market.
• Local Asian companies of Japan, China, Korea and Taiwan offering cost effective products.
Market Drivers
2011 2012 2013 2014 20150.0
50.0
100.0
150.0
200.0
250.0
300.0
350.0
400.0
82.8 94.1 104.1 116.2140.0
170.92185.07
200.10201.19
208.69
APAC($ Billion)
Rest of the World($ Billion)
APAC Medical DevicesLocal Asian companies spur growth through low cost products
Medical Devices Revenues, US$ Bn, 2011-2015
CAGR14.0%CAGR14.0%
CAGR5.1%
CAGR5.1%
26.3 36.6APAC Market Share
• APAC Refurbished market for imaging equipments is expected to reach 9% growth by 2015.
• System interoperability hinders new systems adoption in hospitals.
Market Restraints
• Increased demand for health screening.• Reverse innovation of customized Asian
medical imaging products to cater for different culture and population.
• R & D in medical imaging allows technological advancement - Molecular Imaging, Drug therapy combined with Ultrasound.
Market Drivers
Medical ImagingA technological challenge, new vs refurbished …
Medical Imaging Revenues, US$ Bn, 2011-2015
26.7 32.0APAC Market Share
2011 2012 2013 2014 20150.0
5.0
10.0
15.0
20.0
25.0
30.0
35.0
40.0
45.0
8.8 9.8 11.0 12.2 13.4
24.0425.00
26.1927.54
28.49
APAC($ Billion)
Rest of the World($ Billion)
CAGR11.2%CAGR11.2%
CAGR4.3%
CAGR4.3%
• System interoperability hinders market growth.
• Too many small vendors offering HIT solutions.
Market Restraints
• Quality, regulatory and performance application growing at 11.0% CAGR.
• Patient and Revenue cycle management related application will drive HIT with 10.3% CAGR.
• Departmental Systems market size is expected to be $ 875 million in 2011, growing at 7.1%.
Market Drivers
Healthcare Information TechnologyAPAC HIT growing at global pace of 9.0%
Healthcare IT Revenues, US$ Bn, 2011-2015
20.2 20.5APAC Market Share
2011 2012 2013 2014 20150.0
5.0
10.0
15.0
20.0
25.0
30.0
35.0
40.0
45.0
5.7 6.2 6.8 7.5 8.2
22.5025.29
27.0131.00 31.96
APAC($ Billion)
Rest of the World($ Billion)
CAGR9.7%
CAGR9.7%
CAGR9.2%
CAGR9.2%
Healthcare Delivery Market:Rising middle income, medical tourism create impact
2011 2012 2013 2014 2015 -
50
100
150
200
250
300
350
400
450
500
309334
362
390
420
CAGR 8.0%
APAC Healthcare Delivery Market Size US$ Bn, 2011-2015
Note: All figures are rounded; the base year is 2009. Source: Frost & Sullivan
Market Drivers
• Aging & growing
Population
• Rise in chronic disease
• Medical Tourism
• Rising middle and
affluent income
population
• Manpower shortage
• Access disparity between
urban & rural regions
• Inability to meet demand of
healthcare services in smaller
cities and rural areas
Market Restraints
• International accreditations (e.g. JCI) likely to become the prerequisite for hospitals targeting to participate in medical tourism. Stringent operational and stringent accreditation requirements likely to escalate the clinical and operational quality standards, thus increasing market competitiveness
Healthcare Delivery 2015…
Delivery of health at home
Consolidation of retail healthcare service model
Integration of primary and secondary healthcare facilities. Establishment of electronic medical records integrating
primary and secondary healthcareSatellite based hospital model using advanced medical technologies for
increasing accessibility in rural areas
Healthcare as a service industry
Influx of non-traditional healthcare institutions investments
New models of Holistic healthcare hubs integrating tertiary care, wellness, aged
care and clinical R&D
Increasing funding opportunity for medical tourism through expanded
international medical insurance
Differentiation of hospital models through specialty or holistic health
platforms
The Future of Healthcare . . . .Linking Stakeholders From Different Industries
Community
Education Hospitality
Healthcare
Corporate Wellness
Medical SpaPreventive WellnessMedical WellnessCosmetic SurgeryNutritionalAlternative
SpaFitnessBeautyNutritional
Assisted LifestyleRetirement HomesHealthy VillagesWellness Villages
Primary
Courses
Secondary
Tertiary
Supportive Industries
Where to place your bets: 2012- 2015
Time
Gro
wth
Healthcare manpower
Mobile Healthcare
Hospital services
OTC, Traditional pharmaceuticals, branded generics
INNOVATIONTRIGGER
SUPERGROWTH
LEADERSHIP
IndiaChina
S.Korea
SingaporeMalaysia Vietnam
Source: Frost & Sullivan.
Medical devices, biotech
Digital Imaging
Taiwan
Distribution, manufacturing
Australia
Japan
Monitoring and diagnostics
PhilippinesIndonesia
Thailand
Tier2 and Tier3Healthcare ServiceCenter development
New materials, biotechnology
Specialty based hospitalsvs. Holistic wellness hospitals
Primary and Diagnosticstand alone centers
12
The Frost & Sullivan Story
Pioneered Emerging Market & Technology Research
• Global Footprint Begins
• Country Economic Research
• Market & Technical Research
• Best Practice Career Training
• MindXChange Events
Partnership Relationship with Clients
• Growth Partnership Services
• GIL Global Events
• GIL University
• Growth Team Membership™
• Growth Consulting
Visionary Innovation
• Mega Trends Research
• CEO 360 Visionary Perspective
• GIL Think Tanks
• GIL Global Community
• Communities of Practice
13
What Makes Us Unique
All services aligned on growth to help clients develop and implement innovative growth strategies
Continuous monitoring of industries and their convergence, giving clients first mover advantage in emerging opportunities
More than 40 global offices ensure that clients gain global perspective to mitigate risk and sustain long term growth
Proprietary Team Methodology integrates 7 critical research perspectives to optimize growth investments
Career research and case studies for the CEOs’ Growth Team to ensure growth strategy implementation at best practice levels
Close collaboration with clients in developing their research based visionary perspective to drive GIL
Focused on Growth
IndustryCoverage
Global Footprint
Career Best Practices
360 Degree Perspective
Visionary Innovation Partner
Healthcare – Areas of Expertise
Pharmaceuticals & Biotech
CNS, Oncology, Diabetes, Cardiology, Drug Delivery, Emerging Areas, Pipeline analysis, Biotech Oncology, Drug Delivery Biotechnology, Contract Manufacturing, Contract Research, Ophthalmic, Chronic Diseases
CNS, Oncology, Diabetes, Cardiology, Drug Delivery, Emerging Areas, Pipeline analysis, Biotech Oncology, Drug Delivery Biotechnology, Contract Manufacturing, Contract Research, Ophthalmic, Chronic Diseases
Medical Devices
Cardiovascular Devices Orthopedic Devices, Home Care,
Surgical & Infection Control Pdts, General Medical Devices, Hospital Supplies and ProductsWound Care/ Management Products
Cardiovascular Devices Orthopedic Devices, Home Care,
Surgical & Infection Control Pdts, General Medical Devices, Hospital Supplies and ProductsWound Care/ Management Products
Healthcare and Life Sciences IT
Electronic Medical Records, HISClinical Information Systems,Telemedicine, Life sciences IT,Outsourcing, HealthcareOutsourcing, Clinical SolutionsManaged Care Services,Medical Care Providers,Consumer-based Healthcare
Electronic Medical Records, HISClinical Information Systems,Telemedicine, Life sciences IT,Outsourcing, HealthcareOutsourcing, Clinical SolutionsManaged Care Services,Medical Care Providers,Consumer-based Healthcare
Patient Monitoring
Cardiac MonitoringExternal DefibrillatorsMulti-Parameter MonitoringTemperature MonitoringPulse OximetryRemote Patient MonitoringPatient Monitoring ITSleep Apnea MonitoringGlucose MonitoringBlood Pressure Monitoring
Cardiac MonitoringExternal DefibrillatorsMulti-Parameter MonitoringTemperature MonitoringPulse OximetryRemote Patient MonitoringPatient Monitoring ITSleep Apnea MonitoringGlucose MonitoringBlood Pressure Monitoring
Drug Discovery & Clinical Diagnostics
Genomics, Proteomics,Cellomics, HTS, SNP, IVD,Genetic Testing, MolecularDiagnostics
Genomics, Proteomics,Cellomics, HTS, SNP, IVD,Genetic Testing, MolecularDiagnostics
Medical Imaging
PACS, MRI, Cardiac, CT,Ultrasound, PET, NuclearImaging, Core Imaging
ModalitiesImaging Agents, ImagingSoftware, PACS & ImagingIT , Digital Imaging
PACS, MRI, Cardiac, CT,Ultrasound, PET, NuclearImaging, Core Imaging
ModalitiesImaging Agents, ImagingSoftware, PACS & ImagingIT , Digital Imaging
Pharmaceuticals & Biotech
Cardiology, Hypertension, Diabetes, Oncology, CNS, Pain Management, Respiratory, Women’s Health, Drug Delivery, Emerging Areas, Pipeline Analysis, Vaccines, Antibiotics
Cardiology, Hypertension, Diabetes, Oncology, CNS, Pain Management, Respiratory, Women’s Health, Drug Delivery, Emerging Areas, Pipeline Analysis, Vaccines, Antibiotics
Healthcare Services
Hospital Services, Physicians, Key Opinion Leaders study, Diagnostic centres, Healthcare Institutions,Pharma medical education.
Hospital Services, Physicians, Key Opinion Leaders study, Diagnostic centres, Healthcare Institutions,Pharma medical education.
Financial Services
IPO, Mergers and Acquisition, Strategic Partnership, Business Matching
IPO, Mergers and Acquisition, Strategic Partnership, Business Matching
Growth Tools and MethodologiesOur Thought Leadership on Growth
CEO 360 Perspective
MarketOpportunities
Landscape
Corporate& GrowthObjectives
Growth ExecutionCapabilities
External Internal
Internal
GROWTHZONE
Growth Acceleration System Growth Excellence Matrix
Growth Workshops Growth Pipeline Growth Environment
10 Growth ProcessesBest Practices on Implementation Growth Diagnostic Blueprint
From Macro to Micro: How To Take Mega Trends from Information to Strategy Implementation
Sub TrendA Sub Layer of Trends that Has Wide Ranging Impact
Mega TrendSelected Trends That Impact Your Business
And Markets
Analysis of Opportunities
and Unmet Needs
Impact on Future Product/
Technology
Impact to Your Industry
Visualising The Roadmap Of These Critical Forces Through Scenario Building and Macro
Economic Forecasts
Example: Urbanization, Satellites
Example: Three concepts of urbanization will emerge:
megacities, mega regions and mega corridors. Smart Cities. Civilian satellites means high
speed broadband, wireless and 4G and free wi-fi in public places/cities
Example: New Product Opportunity - New Mega City
Cars, Car sharing,New Technology Opportunities –
Connected car , e.g. Internet Radio
Example: Mega City electric cars with small
turning radius, autonomous parking in
busy cities, Facebook on wheels, seamless
switching from home to car
Example: People in future will need “personal mobility” not necessarily cars to commute to work. This will lead to need for integrated mobility combining all forms of
transport including cars
Macro Micro
http://twitter.com/frost_sullivan
Follow Frost & Sullivan on Facebook, LinkedIn, SlideShare, and Twitter
http://www.facebook.com/FrostandSullivan
http://www.linkedin.com/companies/4506
http://www.slideshare.net/FrostandSullivan
For Additional Information
Donna JeremiahCorporate CommunicationsAsia Pacific+61 (0) 8247 8927 djeremiah@frost.com
Carrie LowCorporate CommunicationsAsia Pacific+603 6204 5910carrie.low@frost.com
Sasikarn Watthanachan Corporate CommunicationsThailand+66 2 637 7414 sasikarn.watt@frost.com
Jessie LohCorporate CommunicationsAsia Pacific+65 6890 0942jessie.loh@frost.com